Literature DB >> 26301969

Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience.

R Nelson1, J F Shapiro1, J B Perkins2, J Kim3,4, T Nishihori4,5, J Pidala4,5, E Ayala4,5, F L Locke4,5, T Field4,5, A Mishra4,5, M Riches4,5, B Betts4,5, L Perez4,5, B Yue3, J L Ochoa-Bayona4,5, M Alsina4,5, H Fernandez4,5, C Anasetti4,5, M A Kharfan-Dabaja4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26301969      PMCID： PMC4863975          DOI： 10.1038/bmt.2015.192

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

1.  HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

Authors:  Nicolaus Kröger; Tatjana Zabelina; Thomas Binder; Francis Ayuk; Ulrike Bacher; Gitta Amtsfeld; Heinrich Lellek; Johanna Schrum; Rolf Erttmann; Thomas Eiermann; Axel Zander
Journal:  Biol Blood Marrow Transplant       Date:  2009-04       Impact factor: 5.742

2.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

3.  A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Jongphil Kim; Heather Jim; Mohamed A Kharfan-Dabaja; Taiga Nishihori; Hugo F Fernandez; Marcie Tomblyn; Lia Perez; Janelle Perkins; Mian Xu; William E Janssen; Anandaraman Veerapathran; Brian C Betts; Frederick L Locke; Ernesto Ayala; Teresa Field; Leonel Ochoa; Melissa Alsina; Claudio Anasetti
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

4.  Anti-thymocyte globulin (thymoglobulin), tacrolimus, and sirolimus as acute graft-versus-host disease prophylaxis for unrelated hematopoietic stem cell transplantation.

Authors:  Zaid Al-Kadhimi; Zartash Gul; Roberto Rodriguez; Wei Chen; Daryn Smith; Alice Mitchell; Muneer Abidi; Lois Ayash; Abhinav Deol; Lawrence Lum; Stephen Forman; Voravit Ratanatharathorn; Joseph Uberti
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-16       Impact factor: 5.742

5.  Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.

Authors:  Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Jens Panse; Christine Wolschke; Thomas Eiermann; Thomas Binder; Boris Fehse; Rudolf Erttmann; Hartmut Kabisch; Ulrike Bacher; Nicolaus Kröger; Axel R Zander
Journal:  Exp Hematol       Date:  2008-05-05       Impact factor: 3.084

6.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

Review 7.  Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.

Authors:  Mohamed A Kharfan-Dabaja; Hillard M Lazarus; Taiga Nishihori; Rami A Mahfouz; Mehdi Hamadani
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-05       Impact factor: 5.742

Review 8.  1994 Consensus Conference on Acute GVHD Grading.

Authors:  D Przepiorka; D Weisdorf; P Martin; H G Klingemann; P Beatty; J Hows; E D Thomas
Journal:  Bone Marrow Transplant       Date:  1995-06       Impact factor: 5.483

9.  Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.

Authors:  G B McDonald; M S Hinds; L D Fisher; H G Schoch; J L Wolford; M Banaji; B J Hardin; H M Shulman; R A Clift
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

10.  A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.

Authors:  S K Khaled; J Palmer; T Stiller; D Senitzer; R Maegawa; R Rodriguez; P M Parker; A Nademanee; J L Cai; D S Snyder; C Karanes; E Osorio; S H Thomas; S J Forman; R Nakamura
Journal:  Bone Marrow Transplant       Date:  2012-09-24       Impact factor: 5.483
View more
  1 in total

1.  Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome.

Authors:  D Modi; A Deol; S Kim; L Ayash; A Alavi; M Ventimiglia; D Bhutani; V Ratanatharathorn; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2017-09-04       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.